This randomised, double-blind, placebo-controlled trial demonstrates the efficacy and safety of the herbal medicinal product Angocin Anti-Infekt N* in the prophylactic treatment of chronically recurrent UTIs.
No takes yet. Share an insight, caveat, or question.
Albrecht et al. (2007) studied this question.
Synapse has enriched one closely related paper. Consider it for comparative context: